Manufacturer
Acertis Pharmaceuticals
- Products listed
- 5
- Molecules
- 4
- Therapy areas
- 0
Acertis Pharmaceuticals is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 5 of its products across 4 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Acertis Pharmaceuticals, LLC, Acertis Pharmaceuticals LLC, Acertis Pharmaceuticals, LLC
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Acertis Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Other products
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Levorphanol 2 mg tabletOralGeneric name | Levorphanol | US FDA | Available on request |
| Licart 0.013 g transdermal systemTopical | Diclofenac epolamine | US FDA | Available on request |
| Phendimetrazine 105 mg extended-release capsuleOralGeneric name | Phendimetrazine | US FDA | Available on request |
| Prometrium 100 mg capsuleOral | Progesterone | US FDA | Available on request |
| Prometrium 200 mg capsuleOral | Progesterone | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Acertis Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.